Stage-specific associations between beta blocker use and prognosis after colorectal cancer (Q57191793)

Is norepinephrine an etiological factor in some types of cancer?

inferred from page(s)

published in

Cancer

0 references

volume

120

0 references

issue

0 references

page(s)

1178-1186

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

The sympathetic nervous system induces a metastatic switch in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Impact of beta blockers on epithelial ovarian cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Beta blocker use and colorectal cancer risk: population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Molecular pathways: beta-adrenergic signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

7 January 2021

inferred from DOI database lookup

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

7 January 2021

inferred from DOI database lookup

A note on quantifying follow-up in studies of failure time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28546

7 January 2021